WO1998024912A3 - Recombinant plague vaccine - Google Patents
Recombinant plague vaccine Download PDFInfo
- Publication number
- WO1998024912A3 WO1998024912A3 PCT/US1997/022617 US9722617W WO9824912A3 WO 1998024912 A3 WO1998024912 A3 WO 1998024912A3 US 9722617 W US9722617 W US 9722617W WO 9824912 A3 WO9824912 A3 WO 9824912A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- recombinant
- present
- cells
- viruses
- molecules
- Prior art date
Links
- 206010035148 Plague Diseases 0.000 title abstract 3
- 241000607479 Yersinia pestis Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 5
- 241001465754 Metazoa Species 0.000 abstract 4
- 210000004027 cell Anatomy 0.000 abstract 2
- 239000013612 plasmid Substances 0.000 abstract 2
- 241000589601 Francisella Species 0.000 abstract 1
- 241000606860 Pasteurella Species 0.000 abstract 1
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 241000607734 Yersinia <bacteria> Species 0.000 abstract 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229940124551 recombinant vaccine Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU55979/98A AU5597998A (en) | 1996-12-04 | 1997-12-04 | Recombinant plague vaccine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76711596A | 1996-12-04 | 1996-12-04 | |
US08/767,115 | 1996-12-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998024912A2 WO1998024912A2 (en) | 1998-06-11 |
WO1998024912A3 true WO1998024912A3 (en) | 1998-09-11 |
Family
ID=25078527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/022617 WO1998024912A2 (en) | 1996-12-04 | 1997-12-04 | Recombinant plague vaccine |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5597998A (en) |
WO (1) | WO1998024912A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003502010A (en) * | 1998-11-18 | 2003-01-21 | インナチュレ リミテッド | Product |
US7344718B2 (en) | 2003-01-31 | 2008-03-18 | University Of North Dakota | Yersinia species compositions |
JP2008528512A (en) | 2005-01-21 | 2008-07-31 | エピトピックス,リミティド ライアビリティ カンパニー | Yersinia SPP. Polypeptides and methods of use |
EP2217716A4 (en) | 2007-11-09 | 2011-02-09 | Salk Inst For Biological Studi | Use of tam receptor inhibitors as antimicrobials |
WO2012178078A2 (en) | 2011-06-22 | 2012-12-27 | University Of North Dakota | Use of yscf, truncated yscf and yscf homologs as adjuvants |
US9328149B2 (en) * | 2013-07-12 | 2016-05-03 | The Catholic University Of America | Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines |
CN114560932B (en) * | 2022-02-18 | 2023-09-12 | 中国人民解放军军事科学院军事医学研究院 | Plague neutralizing antibody and application thereof |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989007140A1 (en) * | 1988-02-05 | 1989-08-10 | Commonwealth Scientific And Industrial Research Or | Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence |
WO1990002484A1 (en) * | 1988-09-06 | 1990-03-22 | Washington University | Oral immunization by transgenic plants |
WO1993001284A1 (en) * | 1991-07-09 | 1993-01-21 | Cornell Research Foundation, Inc. | Recombinant viral vaccine |
WO1993008290A1 (en) * | 1991-10-16 | 1993-04-29 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
US5266313A (en) * | 1987-02-03 | 1993-11-30 | The United States Of America As Represented By The Department Of Health And Human Services | Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms |
WO1994016737A1 (en) * | 1993-01-26 | 1994-08-04 | Weiner David B | Compositions and methods for delivery of genetic material |
WO1994024296A2 (en) * | 1993-04-19 | 1994-10-27 | University Of Saskatchewan | Recombinant bovine herpesvirus type 1 vaccines |
EP0652287A2 (en) * | 1993-09-22 | 1995-05-10 | American Home Products Corporation | Poxviral vectors and their use as a vaccine against feline infectious peritonitis virus disease |
WO1995018231A1 (en) * | 1993-12-24 | 1995-07-06 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection |
WO1996021356A1 (en) * | 1995-01-13 | 1996-07-18 | Vanderbilt University | Methods and compositions for inducing mucosal immune responses |
WO1996028551A1 (en) * | 1995-03-13 | 1996-09-19 | The Secretary Of State For Defence | Vaccines for plague |
-
1997
- 1997-12-04 WO PCT/US1997/022617 patent/WO1998024912A2/en active Application Filing
- 1997-12-04 AU AU55979/98A patent/AU5597998A/en not_active Abandoned
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266313A (en) * | 1987-02-03 | 1993-11-30 | The United States Of America As Represented By The Department Of Health And Human Services | Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms |
WO1989007140A1 (en) * | 1988-02-05 | 1989-08-10 | Commonwealth Scientific And Industrial Research Or | Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence |
WO1990002484A1 (en) * | 1988-09-06 | 1990-03-22 | Washington University | Oral immunization by transgenic plants |
WO1993001284A1 (en) * | 1991-07-09 | 1993-01-21 | Cornell Research Foundation, Inc. | Recombinant viral vaccine |
WO1993008290A1 (en) * | 1991-10-16 | 1993-04-29 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
WO1994016737A1 (en) * | 1993-01-26 | 1994-08-04 | Weiner David B | Compositions and methods for delivery of genetic material |
WO1994024296A2 (en) * | 1993-04-19 | 1994-10-27 | University Of Saskatchewan | Recombinant bovine herpesvirus type 1 vaccines |
EP0652287A2 (en) * | 1993-09-22 | 1995-05-10 | American Home Products Corporation | Poxviral vectors and their use as a vaccine against feline infectious peritonitis virus disease |
WO1995018231A1 (en) * | 1993-12-24 | 1995-07-06 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection |
WO1996021356A1 (en) * | 1995-01-13 | 1996-07-18 | Vanderbilt University | Methods and compositions for inducing mucosal immune responses |
WO1996028551A1 (en) * | 1995-03-13 | 1996-09-19 | The Secretary Of State For Defence | Vaccines for plague |
Non-Patent Citations (1)
Title |
---|
WILLIAMSON E.D. ET AL.: "A new improved sub-unit vaccine for plague: the basis of protection", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, vol. 12, 1 January 1995 (1995-01-01), pages 223 - 230, XP000573083 * |
Also Published As
Publication number | Publication date |
---|---|
AU5597998A (en) | 1998-06-29 |
WO1998024912A2 (en) | 1998-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1783225T3 (en) | Structural protein from AAV, its preparation and use | |
WO1999020766A3 (en) | NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS | |
BR9610511B1 (en) | DNA constructs useful in gene therapy comprising at least one nucleic sequence of interest and pharmaceutical composition. | |
RU95108217A (en) | Defective recombinant adenovirus, cell strain, pharmaceutical composition | |
EP0331939A3 (en) | Method and compositions for conferring resistance to retroviral infection | |
EP2039769A3 (en) | Antimicrobial peptides and methods of use | |
NO962791D0 (en) | Preparations containing nucleic acids, their preparation and use | |
CA2339791A1 (en) | Methods and compositions for cloning nucleic acid molecules | |
WO2001079443A3 (en) | Albumin fusion proteins | |
DK0910406T3 (en) | Recombinant canine herpes virus | |
DE59410380D1 (en) | ENDOSOMOLYTICALLY EFFECTIVE PARTICLES | |
GB2396814A (en) | Vaccine | |
WO2002086144A3 (en) | Compositions and methods for recombinational cloning of nucleic acid molecules | |
AUPN477695A0 (en) | Gene therapy | |
NO983946L (en) | Parapox viruses containing foreign DNA, preparation and use thereof in vaccines | |
WO2000053776A3 (en) | Human kallikrein-like genes | |
WO1998024912A3 (en) | Recombinant plague vaccine | |
ATE171212T1 (en) | CORTICOTROPIN RELEASING FACTOR 2 RECEPTORS | |
WO1994013812A3 (en) | Novel entomopoxvirus genes, proteins and methods of use thereof | |
WO2001040313A3 (en) | Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof | |
WO1995032297B1 (en) | Novel chromosome fragment and its use as a vector | |
EP0256677A3 (en) | Pseudorabies virus recombinants and their use in the production of proteins | |
CA2245545A1 (en) | Vaccines against varicella zoster virus gene 63 product | |
EP1845163A3 (en) | Adeno-associated virus serotype l nucleic acid sequences, vetors and host cells containing same | |
WO2000066743A3 (en) | Viral expression vectors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
CFP | Corrected version of a pamphlet front page |
Free format text: ADD INID NUMBER (63) "RELATED BY CONTINUATION (CON) OR CONTINUATION-IN-PART (CIP) TO EARLIER APPLICATION" WHICH WAS INADVERTENTLY OMITTED FROM THE FRONT PAGE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09319290 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |